Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,984
41 years, by papers

Newest first

2,951 to 3,000 of 3,984

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Efficacy and safety of adding pioglitazone or sitagliptin to patients with type 2 diabetes insufficiently controlled with metformin and a sulfonylurea.

    Endocrine practice2013PMID 23807528

  • Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder.

    The American journal of psychiatry2013PMID 23846733Also indexed under metformin as a PubMed major topic

  • Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.

    The Journal of clinical endocrinology and metabolism2013PMID 23846820Indexed under metformin in PubMed's chemical list

  • Urinary tract infections in patients with diabetes treated with dapagliflozin.

    Journal of diabetes and its complications2013PMID 23849632Indexed under metformin in PubMed's chemical list

  • Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.

    Lancet (London, England)2013PMID 23850055

  • Metformin lowers serum cobalamin without changing other markers of cobalamin status: a study on women with polycystic ovary syndrome.

    Nutrients2013PMID 23857221

  • Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised, placebo controlled trial.

    BMC pediatrics2013PMID 23865839

  • Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.

    Metabolism: clinical and experimental2013PMID 23886298

  • Comparative effects of pioglitazone and metformin on oxidative stress markers in newly diagnosed type 2 diabetes patients: a randomized clinical trial.

    Journal of diabetes and its complications2013PMID 23891275

  • Systematic review of metformin use in obese nondiabetic children and adolescents.

    Hormone research in paediatrics2013PMID 23899569

  • Efficacy of combined metformin-clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS).

    Journal of medicine and life2013PMID 23904883

  • Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia.

    Diabetes, obesity & metabolism2013PMID 23906374Indexed under metformin in PubMed's chemical list

  • Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis.

    Current medical research and opinion2013PMID 23927568

  • Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study.

    Polskie Archiwum Medycyny Wewnetrznej2013PMID 23928867

  • Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review.

    PloS one2013PMID 23936520

  • Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.

    Clinical drug investigation2013PMID 23949898

  • The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes.

    Diabetes/metabolism research and reviews2013PMID 23955995

  • Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study.

    Cardiovascular diabetology2013PMID 23958390

  • Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.

    Diabetes care2013PMID 23963895Indexed under metformin in PubMed's chemical list

  • Does metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both?

    Diabetologia2013PMID 23975325

  • Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.

    The Journal of clinical endocrinology and metabolism2013PMID 23979954

  • Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy.

    Canadian journal of physiology and pharmacology2013PMID 23984793

  • Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant α-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus.

    Diabetes technology & therapeutics2013PMID 23991629Compares against metformin; indexed under metformin in PubMed's chemical list

  • Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes.

    Diabetes research and clinical practice2013PMID 23993469

  • Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control.

    Cardiovascular diabetology2013PMID 24007456Indexed under metformin in PubMed's chemical list

  • Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.

    Endocrine journal2013PMID 24018893Indexed under metformin in PubMed's chemical list

  • Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial.

    Diabetologia2013PMID 24026211

  • A comparative study of the effects of a dipeptidyl peptidase-IV inhibitor and sulfonylurea on glucose variability in patients with type 2 diabetes with inadequate glycemic control on metformin.

    Diabetes technology & therapeutics2013PMID 24050737

  • Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metformin.

    Internal medicine (Tokyo, Japan)2013PMID 24088749

  • Exenatide once weekly versus daily basal insulin as add-on treatment to metformin with or without a sulfonylurea: a retrospective pooled analysis in patients with poor glycemic control.

    Postgraduate medicine2013PMID 24113668

  • Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study.

    International journal of clinical practice2013PMID 24118640

  • Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.

    International journal of clinical practice2013PMID 24118688

  • The effect of metformin on apoptosis in a breast cancer presurgical trial.

    British journal of cancer2013PMID 24157825

  • The effects of metformin on ovarian cancer: a systematic review.

    International journal of gynecological cancer2013PMID 24172091

  • Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.

    Diabetes care2013PMID 24186878Indexed under metformin in PubMed's chemical list

  • Use of metformin and survival of diabetic women with breast cancer.

    Current drug safety2013PMID 24215316

  • Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.

    The oncologist2013PMID 24258613

  • Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer.

    Clinical breast cancer2013PMID 24267731

  • Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.

    American heart journal2013PMID 24268212Indexed under metformin in PubMed's chemical list

  • Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus.

    Hormone research in paediatrics2013PMID 24280743

  • Efficacy of metformin versus insulin in the management of pregnancy with diabetes.

    Journal of the College of Physicians and Surgeons--Pakistan2013PMID 24304990

  • Effects of aerobic exercise with or without metformin on plasma incretins in type 2 diabetes.

    Canadian journal of diabetes2013PMID 24321717

  • Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant.

    Experimental and clinical transplantation2013PMID 24344941Indexed under metformin in PubMed's chemical list

  • Monocyte-suppressing effect of high-dose metformin in fenofibrate-treated patients with impaired glucose tolerance.

    Pharmacological reports2013PMID 24399727

  • Prevalence of vitamin B12 deficiency in patients of type 2 diabetes mellitus on metformin: a case control study from Pakistan.

    The Pan African medical journal2013PMID 24711867Gives metformin alongside what it tests; indexed under metformin in PubMed's chemical list

  • Linearization of the MS response function: case study for metformin assay in plasma samples for bioequivalence purposes.

    Biomedical chromatography2012PMID 21567434

  • Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study.

    The Journal of clinical psychiatry2012PMID 21672497

  • Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.

    Diabetes, obesity & metabolism2012PMID 21812893

  • Metformin and neoplasia: implications and indications.

    Pharmacology & therapeutics2012PMID 21924289

  • A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.

    BJU international2012PMID 21933330

The next 50 papers

← Previous 50